Apollon Wealth Management LLC Buys New Shares in Molina Healthcare, Inc $MOH

Apollon Wealth Management LLC purchased a new position in shares of Molina Healthcare, Inc (NYSE:MOHFree Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,282 shares of the company’s stock, valued at approximately $304,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MOH. AQR Capital Management LLC raised its stake in shares of Molina Healthcare by 217.0% during the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after acquiring an additional 2,008,458 shares in the last quarter. 8 Knots Management LLC bought a new position in shares of Molina Healthcare during the fourth quarter valued at about $198,942,000. Madison Avenue Partners LP purchased a new stake in Molina Healthcare in the 4th quarter worth approximately $110,003,000. Norges Bank purchased a new stake in Molina Healthcare in the fourth quarter worth $109,766,000. Finally, Baupost Group LLC MA purchased a new stake in shares of Molina Healthcare in the 4th quarter worth about $108,463,000. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of Molina Healthcare stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer directly owned 12,815 shares in the company, valued at $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on MOH. Cantor Fitzgerald raised their target price on Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Morgan Stanley raised their price objective on shares of Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research note on Thursday, June 4th. UBS Group lifted their target price on shares of Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $129.00 target price on shares of Molina Healthcare in a research note on Friday, April 24th. Finally, Barclays raised their price target on shares of Molina Healthcare from $161.00 to $199.00 and gave the company an “underweight” rating in a research report on Tuesday, May 26th. Three equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $184.81.

Check Out Our Latest Research Report on Molina Healthcare

Molina Healthcare Price Performance

MOH opened at $227.49 on Tuesday. The company’s 50-day simple moving average is $195.46 and its two-hundred day simple moving average is $171.20. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. The stock has a market capitalization of $11.85 billion, a P/E ratio of 67.30 and a beta of 0.74. Molina Healthcare, Inc has a 52-week low of $121.06 and a 52-week high of $242.50.

Molina Healthcare (NYSE:MOHGet Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. During the same period in the previous year, the business posted $6.08 earnings per share. The business’s revenue for the quarter was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, analysts predict that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Molina Healthcare Company Profile

(Free Report)

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

Featured Articles

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOHFree Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.